Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ascidian Therapeutics is a biotechnology company that specializes in treating human diseases through RNA rewriting. The company's therapeutic approach involves editing exons at the RNA level, allowing for precise post-transcriptional editing of genes. This editing process aims to produce full-length, functional proteins at optimal levels, within the right cells, and at the appropriate times. Ascidian Therapeutics is actively e...
Ascidian Therapeutics is a biotechnology company that specializes in treating human diseases through RNA rewriting. The company's therapeutic approach involves editing exons at the RNA level, allowing for precise post-transcriptional editing of genes. This editing process aims to produce full-length, functional proteins at optimal levels, within the right cells, and at the appropriate times. Ascidian Therapeutics is actively engaged in discovery and preclinical programs focused on a range of conditions, including retinal diseases, neurological disorders, neuromuscular conditions, and genetically defined diseases.

List your booth number for exhibitions, ask us